Evidence map›Paper›PMID 33767630›Full record

ArticleFrontiers in physiology2021

Proteinuria as a Biomarker for COVID-19 Severity.

Hajar Ouahmi, Johan Courjon, Lucas Morand, Juliette François, Vincent Bruckert, Romain Lombardi, Vincent Esnault, Barbara Seitz-Polski, Elisa Demonchy, Jean Dellamonica and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. The relation between proteinuria and the severity of COVID-19.Clinical and experimental nephrology · 2024
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Analytical chemistry · 2022
    Article
  9. Review
  10. Urine sediment findings were milder in patients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renal injuries.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. [Kidney damage in COVID-19].Nephrologie & therapeutique · 2021
    Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Hajar OuahmiService de Médecine Intensive Réanimation, CHU de Nice, Université Côte d'Azur, Nice, France.
Johan CourjonService d'Infectiologie, CHU de Nice, Université Côte d'Azur, Nice, France.
Lucas MorandService de Médecine Intensive Réanimation, CHU de Nice, Université Côte d'Azur, Nice, France.
Juliette FrançoisService de Réanimation CH Antibes-Juan les Pins, Antibes, France.
Vincent BruckertDépartement de réanimation médico-chirugicale et transplantation d'organe, hôpital L'Archet 2, CHU de Nice, Université Côte d'Azur, Nice, France.
Romain LombardiService de Médecine Intensive Réanimation, CHU de Nice, Université Côte d'Azur, Nice, France.
Vincent EsnaultService de Néphrologie-Dialyse-Transplantation, CHU de Nice, Université Côte d'Azur, Nice, France.
Barbara Seitz-PolskiService de Néphrologie-Dialyse-Transplantation, CHU de Nice, Université Côte d'Azur, Nice, France.
Elisa DemonchyService d'Infectiologie, CHU de Nice, Université Côte d'Azur, Nice, France.
Jean DellamonicaService de Médecine Intensive Réanimation, CHU de Nice, Université Côte d'Azur, Nice, France.
Sonia Boyer-SuavetCentre de référence Maladies rares Syndrome néphrotique idiopathique, CHU de Nice, Université Côte d'Azur, Nice, France.
Centre Hospitalier Universitaire de Nice · FRUniversité Côte d'Azur · FRCentre Procédés, Energies Renouvelables et Systèmes Energétiques · FRInserm · FRObservatoire de la Côte d’Azur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRenal involvement in syndrome coronavirus 2 (SARS-CoV-2) infection has been retrospectively described, especially acute kidney injury (AKI). However, quantitative proteinuria assessment and its implication in coronavirus disease 2019 (COVID-19) remain unknown.

methodsIn this prospective, multicenter study in France, we collected clinical and biological data including urinary protein to creatine ratio (UPCR) in patients presenting with moderate to severe COVID-19. Clinical outcome was analyzed according to the level of UPCR.

results42/45 patients (93.3%) had renal involvement (abnormal urinary sediment and/or AKI). Significant proteinuria occurred in 60% of patients. Urine protein electrophoresis showed tubular protein excretion in 83.8% of patients with proteinuria. Inflammatory parametersand D-dimer concentrations correlated with proteinuria level. Patients who required intensive care unit (ICU) admission had higher proteinuria (

conclusionRenal involvement is common in moderate to severe SARS-CoV-2 infection. Proteinuria at baseline is an independent risk factor for increased hospitalization duration and ICU admission in patients with COVID-19.

Indexed as

acute kidney injurybiomarkerCOVID-19kidney involvementpronostic and predictive factorsproteinuriaSARS-CoV-2

Identifiers

PMID33767630
PMCPMC7985082
OpenAlexW3133513134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.